Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 48433-090

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 48433-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structural Formula (Image 01)

Spironolactone Structural Formula (Image 01)
Chemical structure of spironolactone showing molecular formula C24H32O4S and molecular weight 416.57. The image depicts the arrangement of carbon, hydrogen, oxygen, and sulfur atoms in the spironolactone molecule.*
FDA Label Image

Hydrochlorothiazide Structural Formula (Image 02)

Hydrochlorothiazide Structural Formula (Image 02)
Chemical structure of spironolactone, showing the molecular formula C8H8ClN3O4S2 and molecular weight 406.98.*
FDA Label Image

Unit Carton (Image 03)

Unit Carton (Image 03)
Packaging label for Spironolactone and Hydrochlorothiazide tablets by Safecor Health LLC. The predominantly blue label features the UDL logo and notes that the unit dose package is not child resistant, for institutional use only, and provides light resistance. The label includes storage warnings and distributor contact information from Safecor Health LLC.*
FDA Label Image

Spironolactone And Hydrochlorothiazide 25 mg/25 mg Tablets, Usp Unit Carton Label (Image 04)

Spironolactone And Hydrochlorothiazide 25 mg/25 mg Tablets, Usp Unit Carton Label (Image 04)
Spironolactone and Hydrochlorothiazide Tablets, USP 25 mg / 25 mg oral tablets, labeled by Safecor Health LLC. The label indicates a package containing 100 tablets (10 x 10), manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, made in Australia. The image shows the product name in green and black text with dosage strength prominently displayed and includes an imprint on the tablet as well as a barcode on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.